Back
Sarepta Therapeutics Stock Price Chart
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50
SRPT
Sarepta Therapeutics
Last Price:
$58.64
Seasonality Move:
15.14%
7 Day Trial
ALL ACCESS PASS
$
7
The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing slight buying pressure.
Sarepta Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 69.16 | Sell |
| 20-day SMA: | 83.4 | Sell |
| 50-day SMA: | 100.16 | Sell |
| 200-day SMA: | 123.02 | Sell |
| 8-day EMA: | 68.84 | Sell |
| 20-day EMA: | 80.01 | Sell |
| 50-day EMA: | 95.17 | Sell |
| 200-day EMA: | 114.59 | Sell |
Sarepta Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -11.2 | Sell |
| Relative Strength Index (14 RSI): | 23.74 | Sell |
| Chaikin Money Flow: | 16191 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (71.23 - 103.89) | Sell |
| Bollinger Bands (100): | (93.83 - 127.79) | Sell |
Sarepta Therapeutics Technical Analysis
| Mar 20 | Mar 21 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 21 | 24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Sarepta Therapeutics Stock
Is Sarepta Therapeutics Stock a Buy?
-
Sarepta Therapeutics share price is 62.47 while SRPT 8-day simple moving average is 69.16, which is a Sell signal.
-
The stock price of SRPT is 62.47 while Sarepta Therapeutics 20-day SMA is 83.40, which makes it a Sell.
-
Sarepta Therapeutics 50-day simple moving average is 100.16 while SRPT share price is 62.47, making it a Sell technically.
-
SRPT stock price is 62.47 and Sarepta Therapeutics 200-day simple moving average is 123.02, creating a Sell signal.
SRPT Technical Analysis vs Fundamental Analysis
Sell
50
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy or a Sell?
-
Sarepta Therapeutics stock is rated a SellThe current Sarepta Therapeutics [SRPT] share price is $62.47. The Score for SRPT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
Sarepta Therapeutics Stock Info
Market Cap:
6.1B
Price in USD:
62.47
Share Volume:
3.8M
Sarepta Therapeutics 52-Week Range
52-Week High:
173.25
52-Week Low:
60.70
Sell
50
Sarepta Therapeutics (SRPT)
is a Sell
Sarepta Therapeutics Share Price Forecast
-
What is the Sarepta Therapeutics stock price today?The Sarepta Therapeutics stock price is 62.47 USD today.
-
Will SRPT stock go up or go down?Sarepta Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Sarepta Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Sarepta Therapeutics is overvalued.
Is Sarepta Therapeutics Stock a Buy?
-
Sarepta Therapeutics share price is 62.47 while SRPT 8-day exponential moving average is 68.84, which is a Sell signal.
-
The stock price of SRPT is 62.47 while Sarepta Therapeutics 20-day EMA is 80.01, which makes it a Sell.
-
Sarepta Therapeutics 50-day exponential moving average is 95.17 while SRPT share price is 62.47, making it a Sell technically.
-
SRPT stock price is 62.47 and Sarepta Therapeutics 200-day simple moving average is 114.59, creating a Sell signal.
Fundamental Analysis of Sarepta Therapeutics
Is Sarepta Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.
Technical Analysis of Sarepta Therapeutics
Should I short Sarepta Therapeutics stock?
-
SRPT Moving Average Covergence Divergence (MACD) indicator is -11.2, suggesting Sarepta Therapeutics is a Sell
-
Sarepta Therapeutics Relative Strength Index (RSI) is 23.74, which suggest Sarepta Therapeutics is oversold
-
The Bollinger Bands (25) for Sarepta Therapeutics is (71.23 - 103.89), which suggest Sarepta Therapeutics is a Sell
-
The Bollinger Bands (100) for Sarepta Therapeutics is (93.83 - 127.79), which suggest Sarepta Therapeutics is a Sell
* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.